Header Logo

Connection

Leslie Shaw to Area Under Curve

This is a "connection" page, showing publications Leslie Shaw has written about Area Under Curve.
Connection Strength

0.641
  1. Bullock JM, Smith PF, Booker BM, Loughner J, Capozzi D, McCarthy PL, Shaw LM. Development of a pharmacokinetic and Bayesian optimal sampling model for individualization of oral busulfan in hematopoietic stem cell transplantation. Ther Drug Monit. 2006 Feb; 28(1):62-6.
    View in: PubMed
    Score: 0.063
  2. Balis FM, Rieger E, Bunin NJ, Gardiner J, Shaw LM, Olson TS, Milone MC. New approach to busulfan dosing in infants and children based on a population pharmacokinetic analysis. Cancer Chemother Pharmacol. 2025 Feb 11; 95(1):32.
    View in: PubMed
    Score: 0.059
  3. Cousins KAQ, Shaw LM, Shellikeri S, Dratch L, Rosario L, Elman LB, Quinn C, Amado DA, Wolk DA, Tropea TF, Chen-Plotkin A, Irwin DJ, Grossman M, Lee EB, Trojanowski JQ, McMillan CT. Elevated Plasma Phosphorylated Tau 181 in Amyotrophic Lateral Sclerosis. Ann Neurol. 2022 11; 92(5):807-818.
    View in: PubMed
    Score: 0.049
  4. Bonner HS, Shaw LM. New dosing regimens for amifostine: a pilot study to compare the relative bioavailability of oral and subcutaneous administration with intravenous infusion. J Clin Pharmacol. 2002 Feb; 42(2):166-74.
    View in: PubMed
    Score: 0.048
  5. Shaw LM, Korecka M, DeNofrio D, Brayman KL. Pharmacokinetic, pharmacodynamic, and outcome investigations as the basis for mycophenolic acid therapeutic drug monitoring in renal and heart transplant patients. Clin Biochem. 2001 Feb; 34(1):17-22.
    View in: PubMed
    Score: 0.044
  6. Shaw LM, Korecka M, Aradhye S, Grossman R, Bayer L, Innes C, Cucciara A, Barker C, Naji A, Nicholls A, Brayman K. Mycophenolic acid area under the curve values in African American and Caucasian renal transplant patients are comparable. J Clin Pharmacol. 2000 Jun; 40(6):624-33.
    View in: PubMed
    Score: 0.042
  7. Shaw LM, Kaplan B, DeNofrio D, Korecka M, Brayman KL. Pharmacokinetics and concentration-control investigations of mycophenolic acid in adults after transplantation. Ther Drug Monit. 2000 Feb; 22(1):14-9.
    View in: PubMed
    Score: 0.041
  8. Kaplan B, Meier-Kriesche HU, Friedman G, Mulgaonkar S, Gruber S, Korecka M, Brayman KL, Shaw LM. The effect of renal insufficiency on mycophenolic acid protein binding. J Clin Pharmacol. 1999 Jul; 39(7):715-20.
    View in: PubMed
    Score: 0.040
  9. Shaw LM, Bonner HS, Schuchter L, Schiller J, Lieberman R. Pharmacokinetics of amifostine: effects of dose and method of administration. Semin Oncol. 1999 Apr; 26(2 Suppl 7):34-6.
    View in: PubMed
    Score: 0.039
  10. Shaw LM, Mick R, Nowak I, Korecka M, Brayman KL. Pharmacokinetics of mycophenolic acid in renal transplant patients with delayed graft function. J Clin Pharmacol. 1998 Mar; 38(3):268-75.
    View in: PubMed
    Score: 0.036
  11. Perkins J, Field T, Kim J, Kharfan-Dabaja MA, Ayala E, Perez L, Fernandez H, Fancher K, Tate C, Shaw LM, Milone MC, Gardiner JA, Miller S, Anasetti C. Pharmacokinetic targeting of i.v. BU with fludarabine as conditioning before hematopoietic cell transplant: the effect of first-dose area under the concentration time curve on transplant-related outcomes. Bone Marrow Transplant. 2011 Nov; 46(11):1418-25.
    View in: PubMed
    Score: 0.022
  12. de Winter BC, van Gelder T, Sombogaard F, Shaw LM, van Hest RM, Mathot RA. Pharmacokinetic role of protein binding of mycophenolic acid and its glucuronide metabolite in renal transplant recipients. J Pharmacokinet Pharmacodyn. 2009 Dec; 36(6):541-64.
    View in: PubMed
    Score: 0.020
  13. Rhim SY, Park JH, Park YS, Lee MH, Kim DS, Shaw LM, Yang SC, Kang JS. Bioavailability and bioequivalence of two oral formulations of alendronate sodium 70 mg: an open-label, randomized, two-period crossover comparison in healthy Korean adult male volunteers. Clin Ther. 2009 May; 31(5):1037-45.
    View in: PubMed
    Score: 0.020
  14. Rhim SY, Park JH, Park YS, Kim DS, Lee MH, Shaw LM, Kang JS. A sensitive validated LC-MS/MS method for quantification of itraconazole in human plasma for pharmacokinetic and bioequivalence study in 24 Korean volunteers. Pharmazie. 2009 Feb; 64(2):71-5.
    View in: PubMed
    Score: 0.019
  15. Rhim SY, Park JH, Park YS, Lee MH, Hwang KG, Kim YS, Shaw LM, Lee YS, Kang JS. Pharmacokinetics and bioequivalence of 20 mg omeprazole capsule in 24 healthy Korean male volunteers. Int J Clin Pharmacol Ther. 2009 Jan; 47(1):23-9.
    View in: PubMed
    Score: 0.019
  16. Jhee OH, Seo HK, Lee MH, Jeon YC, Shaw LM, Lee SH, Hur Y, Kim KH, Lee HS, Lee SE, Kang JS. Determination of paroxetine in plasma by liquid chromatography coupled to tandem mass spectrometry for pharmacokinetic and bioequivalence studies. Arzneimittelforschung. 2007; 57(7):455-61.
    View in: PubMed
    Score: 0.017
  17. Jhee OH, Lee MH, Shaw LM, Lee SE, Park JH, Kang JS. Pharmacokinetics and bioequivalence study of two brands of loxoprofen tablets in healthy volunteers. Arzneimittelforschung. 2007; 57(8):542-6.
    View in: PubMed
    Score: 0.017
  18. van Gelder T, Le Meur Y, Shaw LM, Oellerich M, DeNofrio D, Holt C, Holt DW, Kaplan B, Kuypers D, Meiser B, Toenshoff B, Mamelok RD. Therapeutic drug monitoring of mycophenolate mofetil in transplantation. Ther Drug Monit. 2006 Apr; 28(2):145-54.
    View in: PubMed
    Score: 0.016
  19. Jhee OH, Jeon YC, Choi HS, Lee MH, Om AS, Lee JW, Hong JW, Kim YS, Kang JC, Lee YS, Shaw LM, Kang JS. Quantitative analysis of tiropramide in human plasma by gas chromatography coupled to mass spectrometry for application to a bioequivalence test. Clin Chim Acta. 2006 Apr; 366(1-2):179-84.
    View in: PubMed
    Score: 0.016
  20. Dalle JH, Wall D, Theoret Y, Duval M, Shaw L, Larocque D, Taylor C, Gardiner J, Vachon MF, Champagne MA. Intravenous busulfan for allogeneic hematopoietic stem cell transplantation in infants: clinical and pharmacokinetic results. Bone Marrow Transplant. 2003 Oct; 32(7):647-51.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.